Noom Med vs ShedRx (2026): prices, structure, verdict

On tirzepatide, only ShedRx↗ has a rankable figure: $289 a month all-in; Noom Med↗ does not offer tirzepatide.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, Noom Med is cheaper: $199 versus $249 a month all-in — a $50 monthly gap, $600 across a year of maintenance dosing, and Noom Med's figure is dose-flat while ShedRx's structure is not.

§ Side by side

§ Each record, read aloud

The two records, condensed

Noom Med: the record, condensed

Noom Med’s semaglutide program bills $199 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $199 is the whole subscription, which makes Noom Med unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #12 of 20 in the verified semaglutide index — $66/month above the floor (Oak Longevity, $133) — and sits $150 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $2,388.

Operationally at Noom Med: shipping included; commitment 12-week cycles; cancellation 12-week billing cycles; pharmacy named (Tailor Made Compounding (named)); states: most states; evidence source-verified, captured 2026-08-08. The full record with source and archive links: the Noom Med page · visit Noom Med ↗

ShedRx: the record, condensed

Start with the load-bearing figure: $289 a month, all-in, is what ShedRx charges for tirzepatide at the 10 mg basis. The structure is tiered: the advertised entry point is $199, but the maintenance figure — the one a full year is actually billed at — is $289. That $90 gap between the ad and the anniversary is the single most important line in this record.

There is no membership line. $289 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

To place the number: #5 of 17 verified programs, with the floor $74/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $160 a month. A year at this figure: $3,468 monthly-billed.

On semaglutide, the number that matters at ShedRx is $249 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. Note the shape: $175 is the number in the marketing, $249 is the number at maintenance. The $74 difference is not a fee or a trick per se — it is dose-tiered pricing doing what dose-tiered pricing does — but it means the advertised figure describes month one, not month twelve.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $249 is the whole subscription, which makes ShedRx unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #13 of 20 in the verified semaglutide index — $116/month above the floor (Oak Longevity, $133) — and sits $100 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,988.

Operationally at ShedRx: shipping included; commitment none month-to-month; cancellation 72-hour notice before the next billing cycle; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the ShedRx page · visit ShedRx ↗

Semaglutide: the duel in full

The semaglutide arithmetic between these two is short: $199 (Noom Med) against $249 (ShedRx). $50 a month sounds survivable; $600 a year is a decision.

Structure sharpens the gap: Noom Med’s figure is dose-flat (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill the same), while ShedRx’s is not — so Noom Med’s number is a ceiling and ShedRx’s advertised entry ($175) is a floor. Comparing a ceiling to a floor flatters the floor; this site compares maintenance to maintenance, which is the table above.

A way to feel the $50 monthly gap: over a year it funds 3.0 extra months at Noom Med’s own rate — the difference is not decoration, it is medication. Over two years it compounds to $1,200, which is the horizon at which structural details (prepaid ladders, membership drag, dose-tier repricing) start mattering more than the sticker itself.

Run the same two programs on the committed basis: Noom Med $199/mo month-to-month against ShedRx $249/mo month-to-month. The order holds: Noom Med leads on both readings, so plan structure sharpens the verdict here rather than reversing it. Whichever basis fits your commitment level, the upfront totals above are the honest units.

§ The clock, run forward

Three, six, twelve, twenty-four months — best path each way

3 months: Noom Med $597 monthly; ShedRx $747 monthly — best path favors Noom Med by $150. 6 months: Noom Med $1,194 monthly; ShedRx $1,494 monthly — best path favors Noom Med by $300. 12 months: Noom Med $2,388 monthly; ShedRx $2,988 monthly — best path favors Noom Med by $600. 24 months: Noom Med $4,776 monthly; ShedRx $5,976 monthly — best path favors Noom Med by $1,200.

Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.

§ Structure vs structure

Everything besides the price

Coverage: Noom Med publishes “most states”; ShedRx publishes “not published” — for anything short of an explicit 50-state claim, intake is the final word.

Pharmacy transparency splits them: Noom Med names its network (Tailor Made Compounding (named)); ShedRx does not, which shifts the burden of verification onto your intake questions.

Exit terms: Noom Med — 12-week cycles; 12-week billing cycles. ShedRx — none month-to-month; 72-hour notice before the next billing cycle.

Evidence: Noom Med source-verified (captured 2026-08-08); ShedRx source-verified (2026-08-05).

The pattern worth internalizing: in this market, structural honesty and price honesty travel together. Programs that publish pharmacies and state lists tend to publish real maintenance prices; programs that hide one usually hide the other.

In the full semaglutide index these two sit at #12 and #13 of 20: between them lie 0 other programs, and the whole ladder is at cheapest semaglutide providers.

§ If you move

Switching between Noom Med and ShedRx

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Noom Med: 12-week billing cycles; ShedRx: 72-hour notice before the next billing cycle) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings